Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4529 (MIR4529) is a non-coding RNA molecule of approximately 21-23 nucleotides found in humans (hsa-miR-4529). As with other microRNAs, MIR4529 is involved in post-transcriptional regulation of gene expression, likely acting by binding to complementary sequences on target messenger RNAs (mRNA), leading to mRNA cleavage, destabilization, or inhibition of protein translation. There is currently no well-established biological function, disease association, or drug interaction specifically attributed to MIR4529 in the published literature. The functional roles described pertain generally to the microRNA family, which is known to regulate important cellular processes such as differentiation, proliferation, and apoptosis, and is implicated in cancer, immune function, and other disease states[1][2][3][4][5][6][7]. Note: Due to lack of direct evidence and reference for MIR4529-specific research, information is inferred from the general properties of microRNAs, as detailed in authoritative reviews and databases[1][4][7].
Not applicable for MIR4529, as there are no drugs currently targeting it. More broadly, drugs targeting microRNAs generally act as miRNA inhibitors or mimics[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4529 (MIR4529).